CXCL10 and central nervous system cancer: Indeed, an increased proliferation of malignant glioma cells compared with normal astrocytes [57] and an anti-apoptotic effect in CXCR3-A-overexpressing human myeloma cell lines (HMCLs) was observed after CXCL10 treatment [58].